Mutual of America Capital Management’s Sarepta Therapeutics SRPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$261K Buy
11,992
+16
+0.1% +$310 ﹤0.01% 1243
2025
Q4
$258K Buy
11,976
+1,031
+9% +$21.7K ﹤0.01% 1235
2025
Q3
$211K Sell
10,945
-37,928
-78% -$676K ﹤0.01% 1283
2025
Q2
$836K Sell
48,873
-288
-0.6% -$12.3K 0.01% 1005
2025
Q1
$3.14M Sell
49,161
-1,296
-3% -$136K 0.04% 639
2024
Q4
$6.14M Sell
50,457
-1,085
-2% -$133K 0.07% 356
2024
Q3
$6.44M Sell
51,542
-2,579
-5% -$357K 0.07% 348
2024
Q2
$8.55M Buy
+54,121
New +$6.95M 0.09% 203
2018
Q2
Sell
-950
Closed -$70K 1718
2018
Q1
$70K Sell
950
-250
-21% -$16.7K ﹤0.01% 1169
2017
Q4
$67K Hold
1,200
﹤0.01% 1174
2017
Q3
$54K Buy
+1,200
New +$48K ﹤0.01% 1192
2016
Q2
Sell
-59,708
Closed -$1.17M 1233
2016
Q1
$1.17M Sell
59,708
-400
-0.7% -$6.99K 0.03% 945
2015
Q4
$2.32M Buy
60,108
+358
+0.6% +$11.6K 0.05% 590
2015
Q3
$1.92M Hold
59,750
0.05% 674
2015
Q2
$1.82M Hold
59,750
0.04% 755
2015
Q1
$793K Sell
59,750
-1,715
-3% -$22.9K 0.02% 1056
2014
Q4
$889K Buy
+61,465
New +$1.04M 0.02% 1031

Other funds holding SRPT